Zhou Yufei, Li Shaoxia, Li Jiangtao, Wang Dongfeng, Li Quanxing
Department of thoracic surgery, Dongying, China.
Department of Pediatrics, The People's Hospital of Dongying, Dongying, China.
Cell Physiol Biochem. 2017;42(4):1431-1446. doi: 10.1159/000479207. Epub 2017 Jul 17.
This study explored the ability of microRNA-135a (miR-135a) to influence cell proliferation, migration, invasion, apoptosis and tumor angiogenesis through the IGF-1/PI3K/Akt signaling pathway in non-small cell lung cancer (NSCLC).
NSCLC tissues and adjacent normal tissues were collected from 138 NSCLC patients. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the expression levels of miR-135a and IGF-1, PI3K, Akt, VEGF, bFGF and IL-8 mRNA; western blotting was used to determine the expression levels of IGF-1, PI3K and Akt protein; and enzyme-linked immunosorbent assay (ELISA) was used to analyze the expression levels of VEGF, bFGF and IL-8 protein. Human NSCLC cell lines (A549, H460, and H1299) and the human bronchial epithelial cell line (HBE) were selected. A549 cells were assigned to blank, negative control (NC), miR-135a mimics, miR-135a inhibitors, IGF-1 siRNA and miR-135a inhibitors + IGF-1 siRNA groups. The following were performed: an MTT assay to assess cell proliferation, a scratch test to detect cell migration, a Transwell assay to measure cell invasion, and a flow cytometry to analyze cell apoptosis.
The expression level of miR-135a was lower while those of IGF-1, PI3K and Akt mRNA were higher in NSCLC tissues than in the adjacent normal tissues. Dual-luciferase reporter assay indicated IGF-1 as a target of miR-135a. The in vitro results showed that compared with the blank group, cell proliferation, migration and invasion were suppressed, mRNA and protein levels of IGF-1, PI3K, Akt, VEGF, bFGF and IL-8 were reduced, and cell apoptosis was enhanced in the miR-135a mimics and IGF-1 siRNA groups. Compared with the IGF-1 siRNA group, cells in the miR-135a inhibitors + IGF-1 siRNA group demonstrated increased cell proliferation, migration and invasion, elevated mRNA and protein levels of IGF-1, PI3K, Akt, VEGF, bFGF and IL-8 and reduced cell apoptosis.
These findings indicated that miR-135a promotes cell apoptosis and inhibits cell proliferation, migration, invasion and tumor angiogenesis by targeting IGF-1 gene through the IGF-1/PI3K/Akt signaling pathway in NSCLC.
本研究探讨微小RNA-135a(miR-135a)通过胰岛素样生长因子-1(IGF-1)/磷脂酰肌醇-3激酶(PI3K)/蛋白激酶B(Akt)信号通路影响非小细胞肺癌(NSCLC)细胞增殖、迁移、侵袭、凋亡及肿瘤血管生成的能力。
收集138例NSCLC患者的NSCLC组织及癌旁正常组织。采用定量实时聚合酶链反应(qRT-PCR)检测miR-135a及IGF-1、PI3K、Akt、血管内皮生长因子(VEGF)、碱性成纤维细胞生长因子(bFGF)和白细胞介素-8(IL-8)mRNA的表达水平;采用蛋白质印迹法检测IGF-1、PI3K和Akt蛋白的表达水平;采用酶联免疫吸附测定(ELISA)分析VEGF、bFGF和IL-8蛋白的表达水平。选取人NSCLC细胞系(A549、H460和H1299)及人支气管上皮细胞系(HBE)。将A549细胞分为空白组、阴性对照组(NC)、miR-135a模拟物组、miR-135a抑制剂组、IGF-1小干扰RNA(siRNA)组和miR-135a抑制剂+IGF-1 siRNA组。进行以下实验:采用MTT法评估细胞增殖,采用划痕试验检测细胞迁移,采用Transwell试验测定细胞侵袭,采用流式细胞术分析细胞凋亡。
NSCLC组织中miR-135a的表达水平低于癌旁正常组织,而IGF-1、PI3K和Akt mRNA的表达水平高于癌旁正常组织。双荧光素酶报告基因试验表明IGF-1是miR-135a的靶标。体外实验结果显示,与空白组相比,miR-135a模拟物组和IGF-1 siRNA组细胞增殖、迁移和侵袭受到抑制,IGF-1、PI3K、Akt、VEGF、bFGF和IL-8的mRNA及蛋白水平降低,细胞凋亡增强。与IGF-1 siRNA组相比,miR-135a抑制剂+IGF-1 siRNA组细胞增殖、迁移和侵袭增加,IGF-1、PI3K、Akt、VEGF、bFGF和IL-8的mRNA及蛋白水平升高,细胞凋亡减少。
这些研究结果表明,在NSCLC中,miR-135a通过IGF-1/PI3K/Akt信号通路靶向IGF-1基因,促进细胞凋亡,抑制细胞增殖、迁移、侵袭及肿瘤血管生成。